Robert Steffen Minneapolis Heart Institute Foundation

Robert Steffen, MD

Cardiothoracic Surgeon

Dr. Robert J. Steffen is a cardiothoracic surgeon at Abbott Northwestern Hospital. He received his medical degree from University of Minnesota Medical School and has been in practice between 11-20 years, and was featured in 2021 as a Top Doctor Rising Star in Mpls. St. Paul Magazine.

Dr. Steffen received his undergraduate education in Biomedical Engineering at Northwestern University. He received his medical degree from the University of Minnesota Medical School. He did his postgraduate training at the Cleveland Clinic. During his training he spent one year as a research fellow in the Department of Thoracic and Cardiovascular Surgery. He was the Chief Resident in his final year of cardiothoracic surgery training and received the Charles Bryan award for Clinical Excellence. Dr. Steffen was a clinical instructor in the Cleveland Clinic Lerner College of Medicine and received multiple teaching awards. 

Dr. Steffen has specific interests in the surgical treatment of hypertrophic cardiomyopathy, valvular heart disease, coronary artery disease, aortic disease, and heart failure. He has published many peer-reviewed manuscripts, book chapters, review articles, and podcasts and has spoken locally, nationally, and internationally on topics in cardiac surgery. 

Back to Board of Directors Back to Valve Team

Robert Steffen Minneapolis Heart Institute Foundation

Professional Interests:

  • Coronary artery bypass
  • Valve repair and replacement
  • Mechanical circulatory support
  • Heart transplantation
  • Hypertrophic cardiomyopathy
  • Aortic surgery
  • Minimally invasive cardiac surgery
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.